Tab Application Banner
  • Users Online: 1083
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
BRIEF REPORT
Year : 2021  |  Volume : 16  |  Issue : 2  |  Page : 200-203

Psychological impact of coronavirus disease 2019 pandemic on patients with rheumatological disorders: A web-based cross-sectional multicentric survey


1 Department of Rheumatology, Manipal Hospital Whitefield, Bengaluru, Karnataka, India
2 Department of Rheumatology, Manipal hospitals, Old Airport Road, Bengaluru, Karnataka, India
3 Department of Rheumatology, Apollo BGS Hospitals, Mysuru, Karnataka, India
4 Department of Rheumatology, Columbia Asia Referral Hospital, Bengaluru, Karnataka, India
5 Department of Rheumatology and Immunology, JSS Academy of Higher Education and research, JSS Medical College, Mysuru, Karnataka, India
6 Department of Rheumatology, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, India
7 Department of Rheumatology, Bhagwan Mahaveer Jain Hospital, Bengaluru, Karnataka, India
8 Department of Clinical Psychology, Manipal hospitals Old Airport Road, Bengaluru, Karnataka, India

Correspondence Address:
Dr. G C Yathish
Department of Rheumatology, Manipal Hospital Whitefield, KR Puram Hobli, Bengaluru - 560 066, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/injr.injr_175_20

Rights and Permissions

Background: The coronavirus disease 2019 (COVID-19) pandemic has resulted in uncertainty and negative psychological outcomes for patients with autoimmune rheumatic diseases for several reasons. It is essential to understand the level of anxiety among rheumatic disease patients at the current situation of COVID-19. Objectives and Methods: A web-based cross-sectional multicenter survey was done across 5 rheumatology centers in India. The study duration was between 9th May and May 16, 2020. The questionnaire included consent, demographic details, medication history, opinion about tele rheumatology services, and anxiety score measured by Beck Anxiety Inventory. Results: The survey was sent to 2987 patients, there were 933 responses, and 581 were complete (male = 175). Complete responses were considered for data analysis. Rheumatoid arthritis was the most frequent (50.6%) diagnosis followed by other conditions. Most of the patients (43%) were on combination disease-modifying anti-rheumatic drug therapy, 12.7% of patients were on biological drugs, and 23.9% of patients were on glucocorticoids (GCs). Statistically significant higher anxiety scores were observed in females (8.79 ± 9.3), fibromyalgia patients (19.78 ± 14.8), patients on GCs (9.26 ± 8.8), and biological agents (10.65 ± 10.6). Difficulty in meeting rheumatologists and getting medications was expressed by 327 (56.2%) and 73 (29.7%) respondents, respectively. Conclusion: The findings of the study revealed that anxiety is a major concern in patients with autoimmune rheumatic diseases. Fibromyalgia patients and those who were on GC and biological drugs were found to have more anxiety levels compared to other groups of patients. There is a need to intensify the awareness and address the mental health issues.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed926    
    Printed32    
    Emailed0    
    PDF Downloaded51    
    Comments [Add]    

Recommend this journal